CommentaryPublished 29 Sep 2022
Hypertensive Nephropathy: Huangqi Injection Treatment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The extract of Astragalus membranaceus (Fisch.) Bunge is known as uangqi injection (HQI), and it is frequently used in China to treat a wide range of illnesses. It is expected to have a significant role in hypertensive nephropathy adjuvant therapy. HQI and antihypertensive medications should be evaluated for their effectiveness in treating hypertensive nephropathy. When combined with antihypertensive medications, HQI is more effective than antihypertensive medications alone at improving associated indexes in patients with hypertensive nephropathy, and a moderate dose of HQI may be more beneficial. The methodology's poor quality and the study's small sample size mean that further rigorous randomised controlled trials are required to corroborate the findings.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHealth Economics & Outcome Research: Open Access
- SubjectBusiness & Management
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Wiatt Iluka”
